Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Oman has been steadily increasing in recent years.
Customer preferences: Customers in Oman are increasingly seeking out dermatological drugs for a variety of skin conditions, including eczema, psoriasis, and acne. This trend is in line with the growing awareness of the importance of skincare and the increasing availability of dermatological drugs in the market.
Trends in the market: One of the key trends in the dermatological drugs market in Oman is the increasing availability of over-the-counter (OTC) products. This has made it easier for consumers to access these drugs without a prescription, which has contributed to the growth of the market. Another trend is the increasing use of natural and organic ingredients in dermatological drugs, as consumers become more conscious of the potential side effects of synthetic chemicals.
Local special circumstances: One of the unique aspects of the dermatological drugs market in Oman is the high prevalence of skin conditions such as eczema and psoriasis. This is due in part to the country's hot and arid climate, which can be harsh on the skin. As a result, there is a strong demand for effective dermatological treatments that can address these conditions.
Underlying macroeconomic factors: The growth of the dermatological drugs market in Oman is also being driven by broader macroeconomic factors, such as the country's growing population and increasing disposable income levels. As more people are able to afford these products, the demand for dermatological drugs is likely to continue to rise. Additionally, the government's focus on improving healthcare infrastructure and increasing access to medical treatments is also expected to contribute to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
